Biocept, Inc., develops and commercializes molecular diagnostic laboratory assays that provide physicians & other healthcare providers with clinically actionable information to aid in the diagnosis, treatment, & monitoring of patients with cancer. Biocept developed the CNSide™ CSF assay, designed to diagnose cancer that has metastasized to the CNS.